Datin Dr. Asmahan Mohamed Ismail is a distinguished Rheumatologist with a profound commitment to advancing autoimmune disease treatment. Her expertise is underscored by significant research contributions, including profiling tofacitinib treatment responses in rheumatoid arthritis and assessing real-world efficacy of bDMARDs in Malaysian patients. She is also a dedicated advocate for patient education, notably participating in public awareness campaigns on Systemic Lupus Erythematosus (SLE).